Volume 6, Issue 11: CFTR Modulation: Today and Tomorrow
e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 6, Issue 11)
Target Audience
Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Summarize the recent clinical trials of CFTR modulators and their use for different CFTR mutations in genotyped patients with cystic fibrosis.
- Explain optimizing the use of CFTR modulators to maximize the health care benefits.
- Discuss the challenges and future directions for the development of CFTR modulators for all patients with cystic fibrosis.
Claire Wainwright, MBBS, MRCP, FRACP, MD
Professor
University of Queensland
Lady Cilento Children’s Hospital
Brisbane, Australia
Tonia Douglas, FRACP, MD
Senior Clinical Lecturer
University of Queensland
Lady Cilento Children's Hospital
Brisbane, Australia
Available Credit
- 1.00 ANCC
- 1.00 Attendance